Tuesday, December 24, 2019
11:19 AM EST – BriaCell Therapeutics Corp. : Has approved a consolidation of the Company’s issued and outstanding common shares on the basis of 300 pre-consolidation shares for one post-consolidated share. The purpose of the Consolidation is to facilitate the Company’s ability to list on a recognized stock exchange in the United States of America. The effective date for the Consolidation will be January 2, 2020. BriaCell Therapeutics Corp. (V.BCT) shares were unchanged at 0.05.
Stocks in Play: BriaCell Therapeutics Corp., Tue, 24 Dec 2019 11:27:57 EST